Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation.

Curry, Benjamin J; Rikken, A O F Sem; Gibson, C Michael; Granger, Christopher B; van 't Hof, Arnoud W J; Ten Berg, Jurriën M; Jennings, Lisa K

Curry, Benjamin J; Rikken, A O F Sem; Gibson, C Michael; Granger, Christopher B; van 't Hof, Arnoud W J; Ten Berg, Jurriën M; Jennings, Lisa K.

Afiliação

Curry BJ; MLM Medical Labs, 140 Collins Street, Memphis, TN, 38117, USA.
Rikken AOFS; St. Antonius Hospital, Nieuwegein, The Netherlands.
Gibson CM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.
Granger CB; Boston Clinical Research Institute, Boston, MA, USA.
van 't Hof AWJ; Department of Cardiology, Duke University School of Medicine, Durham, NC, USA.
Ten Berg JM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.
Jennings LK; MUMC+, Maastricht, The Netherlands.

J Thromb Thrombolysis ; 56(4): 499-510, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37563502

Palavras-chave

Glycoprotein IIb-IIIa; P2Y12; Platelet; Selatogrel; Zalunfiban

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Thromb Thrombolysis Assunto da revista: ANGIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google